Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 8;5(12):2284-2291.
doi: 10.1016/j.ekir.2020.09.040. eCollection 2020 Dec.

Worldwide Disparity in the Relation Between CKD Prevalence and Kidney Failure Risk

Marieke H C van Rijn  1   2 , Natalia Alencar de Pinho  2 , Jack F Wetzels  1 , Jan A J G van den Brand  1 , Benedicte Stengel  2
Affiliations

Worldwide Disparity in the Relation Between CKD Prevalence and Kidney Failure Risk

Marieke H C van Rijn et al. Kidney Int Rep. .

Abstract

Introduction: The incidence of kidney replacement therapy (KRT) for kidney failure varies internationally much more than chronic kidney disease (CKD) prevalence. This ecologic study investigated the relation of CKD prevalence to KRT and mortality risks by world region.

Methods: We used data from Global Burden of Disease and KRT registries worldwide with linear models to estimate the percentages of variance in KRT incidence and all-cause mortality explained by age-adjusted prevalence of CKD stages 3 to 5, overall and by gender, in 61 countries classified in 3 regions: high income (n = 28), Eastern and Central Europe (n = 15), and other (n = 18).

Results: The incidence of KRT ranged from 89 to 378 per million population in high-income regions, 32 to 222 per million population in Central and Eastern Europe, and 22 to 493 per million population in the other region; age-adjusted CKD prevalence ranged from 5.5% to 10.4%, 7.6% to 13.7%, and 7.4% to 13.1%, respectively. The relation between these indicators was positive in high-income countries, negative in Central and Eastern Europe, and null in the other region. Age-adjusted CKD prevalence explained 40% of the variance in KRT incidence (P < 0.001) in high-income countries. The explained variance of age-adjusted mortality was close to 0 in high-income countries and positive at 19% (P = 0.10) in Central and Eastern Europe and at 11% (P = 0.17) in the other region. Results were consistent by gender.

Conclusion: This study raises awareness on the significant part of the gaps in KRT incidence across countries not explained by the number of individuals with CKD, even in high-income countries where access to KRT is not limited.

Keywords: chronic kidney disease; disparity; ecologic study; international comparison; kidney replacement therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Incidence of kidney replacement therapy (KRT) according to age-standardized chronic kidney disease (CKD) prevalence, by region. pmp, per million population.
Figure 2
Figure 2
Age-standardized all-cause mortality according to age-standardized chronic kidney disease (CKD) prevalence, by region.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Jha V., Garcia-Garcia G., Iseki K. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–272. - PubMed
    1. Nitsch D., Grams M., Sang Y. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ. 2013;346:f324. - PMC - PubMed
    1. Thomas B., Matsushita K., Abate K.H. Global cardiovascular and renal outcomes of reduced GFR. J Am Soc Nephrol. 2017;28:2167–2179. - PMC - PubMed
    1. Caskey F.J., Jager K.J. A population approach to renal replacement therapy epidemiology: lessons from the EVEREST study. Nephrol Dial Transplant. 2014;29:1494–1499. - PubMed
    1. Liyanage T., Ninomiya T., Jha V. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975–1982. - PubMed